p.102 抽出テキスト

insights from the ISCHEMIA trial. Circulation 2020;142:1725–35. https://doi. org/10.1161/CIRCULATIONAHA.120.050304 733. Iaconelli A, Pellicori P, Dolce P, Busti M, Ruggio A, Aspromonte N, et al. Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials. Eur J Heart Fail 2023;25:1094–104. https://doi.org/10.1002/ejhf.2911 734. Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Nowbar AN, Simader FA, Davies JR, et al. A placebo-controlled trial of percutaneous coronary intervention for stable angina. N Engl J Med 2023;389:2319–30. https://doi.org/10. 1056/NEJMoa2310610 735. Spertus JA, Jones PG, Maron DJ, O’Brien SM, Reynolds HR, Rosenberg Y, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med 2020;382:1408–19. https://doi.org/10.1056/ NEJMoa1916370 736. Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 2017;38:3351–8. https://doi.org/10.1093/eurheartj/ehx381 737. Shahim B, Shahim A, Adamo M, Chioncel O, Benson L, Crespo-Leiro MG, et al. Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2023;25:1049–60. https://doi.org/10.1002/ejhf.2908 738. Krittanawong C, Kumar A, Wang Z, Johnson KW, Rastogi U, Narasimhan B, et al. Predictors of in-hospital mortality after transcatheter aortic valve implantation. Am J Cardiol 2020;125:251–7. https://doi.org/10.1016/j. amjcard.2019.10.014 739. Adamo M, Pagnesi M, Chioncel O, Bayes-Genis A, Abdelhamid M, Antohi EL, et al. Management of aortic stenosis and chronic heart failure: a clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur J Heart Fail 2025;27:2623–33. https://doi.org/10.1002/ejhf.70023 740. Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, Gonzalez Ferreiro R, Gonzalez Bermudez I, Lopez Otero D, et al. Dapagliflozin in patients undergoing transcatheter aortic-valve implantation. N Engl J Med 2025;392: 1396–405. https://doi.org/10.1056/NEJMoa2500366 741. Elder DH, Wei L, Szwejkowski BR, Libianto R, Nadir A, Pauriah M, et al. The impact of renin–angiotensin–aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol 2011;58:2084–91. https:// doi.org/10.1016/j.jacc.2011.07.043 742. Jung JC, Jang MJ, Hwang HY. Meta-analysis comparing mitral valve repair versus replacement for degenerative mitral regurgitation across all ages. Am J Cardiol 2019;123:446–53. https://doi.org/10.1016/j.amjcard.2018. 10.024 743. Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation 2017;135:410–22. https://doi.org/10. 1161/CIRCULATIONAHA.116.023340 744. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015;66:2844–54. https:// doi.org/10.1016/j.jacc.2015.10.018 745. Makkar RR, Chikwe J, Chakravarty T, Chen Q, O’Gara PT, Gillinov M, et al. Transcatheter mitral valve repair for degenerative mitral regurgitation. JAMA 2023;329:1778–88. https://doi.org/10.1001/jama.2023.7089 746. Bartko PE, Heitzinger G, Pavo N, Heitzinger M, Spinka G, Prausmuller S, et al. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ 2021;373: n1421. https://doi.org/10.1136/bmj.n1421 747. Adamo M, Chioncel O, Benson L, Shahim B, Crespo-Leiro MG, Anker SD, et al. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: an analysis from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 2023;25:1061–71. https://doi.org/10.1002/ejhf.2929 748. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611–44. https://doi.org/10.1093/ehjci/jet105 749. Riccardi M, Cikes M, Adamo M, Pagnesi M, Lombardi CM, Solomon SD, et al. Functional mitral regurgitation and heart failure with preserved ejection fraction: clinical implications and management. J Card Fail 2024;30:929–39. https://doi.org/10.1016/j.cardfail.2024.02.024 750. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297–306. https://doi.org/10. 1056/NEJMoa1805374 751. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307–18. https://doi.org/10.1056/NEJMoa1806640 752. Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, et al. Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation. N Engl J Med 2024;391:1799–809. https://doi.org/10.1056/ NEJMoa2314328 753. Anker MS, Porthun J, Bonnet G, Schulze PC, Rassaf T, Landmesser U. Percutaneous transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure: a meta-analysis of 3 randomized controlled trials. J Am Coll Cardiol 2024;84:2364–8. https://doi.org/10.1016/j.jacc. 2024.08.026 754. Baldus S, Doenst T, Pfister R, Gummert J, Kessler M, Boekstegers P, et al. Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med 2024;391:1787–98. https://doi.org/10.1056/ NEJMoa2408739 755. Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 2023;388:2037–48. https://doi.org/10.1056/ NEJMoa2300213 756. Adamo M, Fiorelli F, Melica B, D’Ortona R, Lupi L, Giannini C, et al. COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing MitraClip implantation. JACC Cardiovasc Interv 2021;14:15–25. https://doi.org/10.1016/j.jcin.2020.09.050 757. Adamo M, Pagnesi M, Ajmone Marsan N, Bauersachs J, Hausleiter J, Zieroth S, et al. Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach. Eur Heart J 2025;47:1294–303. https://doi.org/10.1093/eurheartj/ehaf480 758. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695–705. https://doi.org/10. 1056/NEJMoa1814052 759. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607. https://doi. org/10.1056/NEJMoa1008232 760. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790–8. https://doi.org/10.1056/NEJMoa1400590 761. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in lowrisk patients. N Engl J Med 2019;380:1706–15. https://doi.org/10.1056/ NEJMoa1816885 762. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014;63:1972–81. https://doi.org/10.1016/j.jacc.2014.02. 556 763. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321–31. https://doi. org/10.1056/NEJMoa1700456 764. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187–98. https://doi.org/10.1056/ NEJMoa1103510 765. Ueyama H, Kuno T, Harrington M, Takagi H, Krishnamoorthy P, Sharma SK, et al. Impact of surgical and transcatheter aortic valve replacement in lowgradient aortic stenosis: a meta-analysis. JACC Cardiovasc Interv 2021;14: 1481–92. https://doi.org/10.1016/j.jcin.2021.04.038 766. Mack M, Carroll JD, Thourani V, Vemulapalli S, Squiers J, Manandhar P, et al. Transcatheter mitral valve therapy in the United States: a report from the STS/ACC TVT Registry. Ann Thorac Surg 2022;113:337–65. https://doi. org/10.1016/j.athoracsur.2021.07.030 767. Saji M, Yamamoto M, Kubo S, Asami M, Enta Y, Shirai S, et al. Short-term outcomes following transcatheter edge-to-edge repair: insights from the OCEAN-Mitral registry. JACC Asia 2023;3:766–73. https://doi.org/10. 1016/j.jacasi.2023.06.008 768. Koell B, Orban M, Weimann J, Kassar M, Karam N, Neuss M, et al. Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair. J Am Coll Cardiol 2021;78:2408–21. https://doi.org/10.1016/j.jacc.2021.10.011 769. Stocker TJ, Stolz L, Karam N, Kalbacher D, Koell B, Trenkwalder T, et al. Long-term outcomes after edge-to-edge repair of secondary mitral Downloaded from academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302 by guest on 31 August 2026